Atglistatin is a highly potent, selective and competitive inhibitor of adipose triglyceride lipase (ATGL) with an IC50 of ~0.7 M for inhibition of lipolysis in vitro, but no toxicity up to a concentration of 50 M.
For research use only. We do not sell to patients.